TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MILLA PHARMS

NeurologyCardiovascularMetabolic
Generics

MILLA PHARMS is a generic drug manufacturer focused on Neurology, Cardiovascular, Metabolic. Key products include TRANEXAMIC ACID.

2017
Since
9
Drugs
-
Trials
97
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
TRANEXAMIC ACID 2026-01-26
PYRIDOSTIGMINE BROMIDE 2025-09-26
Labeling
SODIUM ACETATE 2025-09-18
PHENYLEPHRINE HYDROCHLORIDE 2025-09-17
Manufacturing (CMC)
TRANEXAMIC ACID 2025-08-20
Labeling
TRANEXAMIC ACID 2025-08-19
SODIUM ACETATE 2025-08-08
TRANEXAMIC ACID 2025-06-11
TRANEXAMIC ACID 2025-06-09
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%
2 drugs
Cardiovascular 25%
1 drugs
Metabolic 25%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Novo Nordisk big-pharma
Metabolic, Cardiovascular, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Metabolic
AZURITY specialty
Cardiovascular, Neurology, Metabolic
Merck big-pharma
Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Cardiovascular, Metabolic